Develops pharmaceutical products

TwinStrand Biosciences improves the accuracy of DNA sequencing by >10,000 fold and allows detection of mutations that are invisible by other approaches, through its technology. Its technology, Duplex Sequencing, is based on research and has potential applications in a wide range of fields, including oncology, infectious disease, organ transplantation, reproductive and genetic health, and forensics.

Novavax is a biotechnology company that promotes improved health globally through the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases. Novavax recently initiated the development of NVX-CoV2373, its vaccine candidate against SARS-CoV-2, the virus that causes COVID-19, with Phase 1 clinical trial results expected in July 2020. NanoFlu™, its quadrivalent influenza nanoparticle vaccine, met all primary objectives in its pivotal Phase 3 clinical trial in older adults. Both vaccine candidates incorporate Novavax’s proprietary saponin-based Matrix-M™ adjuvant in order to enhance the immune response and stimulate high levels of neutralizing antibodies. Novavax is a leading innovator of recombinant vaccines; its proprietary recombinant technology platform combines the power and speed of genetic engineering to efficiently produce highly immunogenic nanoparticles in order to address urgent global health needs.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Wuhan Jiaoyun Huizhi Information Technology Co., Ltd., established on 2016-06-12, Business scope includes licensed projects:Construction engineering design;Construction Engineering Construction(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:software development;software sales;Information system integration service;Computer System Services;graphic design;Data processing and storage support services;Information system operation and maintenance services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Information Technology Consulting Services;Network technology service;Security equipment sales;General machinery and equipment installation services;Wholesale of computer software, hardware and auxiliary equipment;Retailing of computer software, hardware and auxiliary equipment;electronics sales;Sales of power electronic components;Machinery sales;Electrical Equipment Sales;IoT Device Sales;Internet of Things Technology Services;Internet of things technology research and development;Communication equipment sales(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Shenyang Institute of Automation (Chinese: 沈阳自动化研究所) of the Chinese Academy of Sciences (CAS) was founded in 1958. It is mainly engaged in mechatronic engineering, pattern recognition and intelligent system, control theory and control engineering, computer applied technology.

Dalian Hailian Automatic Control Co., Ltd., established on 2009-05-21, Business scope includes industrial automatic control system,computer software,Marine supporting equipment,Ship automation,detection,surveillance system,Teaching equipment,Distribution switch control equipment,transformer,Reactor design,to develop,technical consulting,technology transfer,Technical Services;(The above items involve administrative licensing,The operating permit)Domestic general trade,Import and export,Technology Import and Export(law,Except for items prohibited by administrative regulations;law,Projects restricted by administrative regulations can only be operated after obtaining a license).****(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Chengdu Chengdian Power Engineering Design Co., Ltd., established on 2002-08-01, Business scope includes licensed projects:Construction engineering design;Construction Engineering Survey;Construction Project Supervision;Construction Engineering Construction;power transmission,powered by,Installation of power receiving facilities,Repair and Test;Geological Hazard Risk Assessment;Mapping service;General Aviation Services;Safety Evaluation Business(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Engineering cost consulting business;Engineering Management Services;Planning and Design Management;Emerging energy technology research and development;Engineering technical service(planning management,survey,design,Except supervision);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Environmental Protection Monitoring;Environmental Consulting Services;Soil Erosion Prevention and Control Services;Bidding agency service;Purchasing agency service;Sales of building materials;Communication equipment sales;Intelligent power transmission and distribution and control equipment sales;Sales of generators and generator sets;Retailing of computer software, hardware and auxiliary equipment;software development;software sales;Information Consulting Service(Not including licensing information consulting services);Information Technology Consulting Services;Geographic Remote Sensing Information Service;Social Stability Risk Assessment;Energy saving management service;Foreign contracted projects;Fire technical service;Personal Business Services;Non-residential real estate leases(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria.

Serono Genetics Institute SA, a subsidiary of Merck KGaA, is a French company located in Paris. The firm operates a biotechnology company specializing in synthetic DNA and genetic analysis. It was founded in 1989 by Pascal Brandys. Serono Genetics Institute SA was acquired by Serono SA on September 23, 2002 for $65.82 million.

SGCC was founded on Dec. 29th, 2002 as a pilot state-owned corporation by the State Council. As a backbone state-owned enterprise that may affect national energy safety and economic lifelines, SGCC's core business is to build and operate power grids and provides secure and reliable power supply for the development of the society. With a registered capital of RMB 200 billion yuan and service area covering 26 provinces,autonomous regions and municipalities directly under the jurisdiction of the Central Government which equals to 88% of the national territory. SGCC carries out the president responsibility system. The president is the legal corporate representative of SGCC. By the end of 2005, SGCC accumulated a total asset of RMB1176.7 billion yuan with a debt-asset ratio of 61.96%, and possessed 195,899 km of 220kV and above transmission lines with a transforming capacity up to 616.64 GVA. SGCC has 1.502 million employees and serves 128 million customers. In 2005, SGCC sold electric power up to 1464.6 TWh and achieved an operation income of RMB 721.4 billion yuan with a net profit of RMB14.4 billion yuan profit & tax of RMB 60.4 billion yuan. SGCC was ranked the 40th in the Fortune Global 500 in 2005.

Discover Turing Technology (Xi'an) Co., Ltd., established on 2017-07-10, Business scope includes general items:Artificial intelligence public data platform;Artificial intelligence general application system;Artificial intelligence industry application system integration service;AI Hardware Sales;software development;Research and development of intelligent robots;internet data service;Educational Consulting Services(Education and training activities that do not include licensing approval);Experimental analysis instrument sales;Teaching equipment sales;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Data processing and storage support services;Cloud Computing Equipment Sales;Computer System Services;Internet of Things Technology Services;Internet of things technology research and development;IoT Device Sales;Retailing of computer software, hardware and auxiliary equipment;Intelligent control system integration;navigation,surveying and mapping,Sales of Meteorological and Oceanographic Special Instruments;Communication equipment sales;electronics sales;Communication equipment sales;Conference and Exhibition Services;Information Technology Consulting Services;Business Management Consulting;Organize cultural and artistic exchange activities.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Changchun Power Supply Company of State Grid Jilin Electric Power Co., Ltd., established on 1986-05-19, Business scope includes power supply in Changchun area,Motor vehicle charging sales(law,Projects prohibited by regulations and decisions of the State Council shall not be operated,Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Vaximm is focused on developing active immunotherapies (vaccines) for patients suffering from cancer. Their initial product candidate VXM01 is targeting the tumor vasculature, which is essential for tumors to grow beyond microscopic size. Vaximm has shown impressive anti-tumor activity in various animal studies and will enter first human clinical trials in 2011.